ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
AB Science Paris (CE)

AB Science Paris (CE) (ABSCF)

1.26
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.26
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.80 52 Week Range 1.60
Market Cap
Previous Close
1.26
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
247
Shares Outstanding
52,071,069
Dividend Yield
-
PE Ratio
-9.11
Earnings Per Share (EPS)
-0.15
Revenue
1.25M
Net Profit
-7.83M

About AB Science Paris (CE)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
AB Science Paris (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ABSCF. The last closing price for AB Science Paris (CE) was $1.26. Over the last year, AB Science Paris (CE) shares have traded in a share price range of $ 0.80 to $ 1.60.

AB Science Paris (CE) currently has 52,071,069 shares outstanding. The market capitalization of AB Science Paris (CE) is $65.61 million. AB Science Paris (CE) has a price to earnings ratio (PE ratio) of -9.11.

ABSCF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4001.261.261.264001.26CS
12-0.34-21.251.61.61.262471.41621622CS
260.4657.50.81.60.81491.32211538CS
520.218.86792452831.061.60.83921.03330059CS
156-9.34-88.113207547210.610.61.0E-660542.66705617CS
260-8.505-87.09677419359.76526.71.0E-6283011.39175682CS

ABSCF - Frequently Asked Questions (FAQ)

What is the current AB Science Paris (CE) share price?
The current share price of AB Science Paris (CE) is $ 1.26
How many AB Science Paris (CE) shares are in issue?
AB Science Paris (CE) has 52,071,069 shares in issue
What is the market cap of AB Science Paris (CE)?
The market capitalisation of AB Science Paris (CE) is USD 65.61M
What is the 1 year trading range for AB Science Paris (CE) share price?
AB Science Paris (CE) has traded in the range of $ 0.80 to $ 1.60 during the past year
What is the PE ratio of AB Science Paris (CE)?
The price to earnings ratio of AB Science Paris (CE) is -9.11
What is the cash to sales ratio of AB Science Paris (CE)?
The cash to sales ratio of AB Science Paris (CE) is 57.08
What is the reporting currency for AB Science Paris (CE)?
AB Science Paris (CE) reports financial results in EUR
What is the latest annual turnover for AB Science Paris (CE)?
The latest annual turnover of AB Science Paris (CE) is EUR 1.25M
What is the latest annual profit for AB Science Paris (CE)?
The latest annual profit of AB Science Paris (CE) is EUR -7.83M
What is the registered address of AB Science Paris (CE)?
The registered address for AB Science Paris (CE) is 3 AVENUE GEORGE V, PARIS, PARIS, 75008
What is the AB Science Paris (CE) website address?
The website address for AB Science Paris (CE) is www.ab-science.com
Which industry sector does AB Science Paris (CE) operate in?
AB Science Paris (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0

Discussion

View Full Feed
Monksdream Monksdream 3 minutes ago
INM
INM
GoodGuyBill GoodGuyBill 4 minutes ago
Most people who disagree with a particular claim do so by presenting counter arguments not baseless personal attacks. This response to a reasonable post lakes any credibility whatsoever. I don't understand how posts like this-- referring to people as liars, are allowed. TOS violation?
NWBO
pepeoil pepeoil 4 minutes ago
Oh yea Joshy, I don’t see you on the Texas RRC approved pluggers list. You can’t do it yourself. Bwahaaaaaa. You have to hire someone to come crush your cement. Bwahaaaaa.
AZRH
Scotty9 Scotty9 4 minutes ago
O my prophet what else do you see in the tickers please tell us all
TWOH
Monksdream Monksdream 6 minutes ago
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
June 24 2025 - 7:00AM

Alert
Print
Share On Facebook

iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of next-generation antibody
IBIO
Investor2014 Investor2014 7 minutes ago
We have no idea and just invest because it all sounds cool or believe TA will tell us, so you seem to have joined the right party.
AVXL
Monksdream Monksdream 8 minutes ago
Top 15
https://www.advfn.com/markets/nasdaq/premarket
JayB2022 JayB2022 8 minutes ago
NTRR
Cameo Brien Cameo Brien 9 minutes ago
Current Price: ~$0.58 (as of June 23, 2025)  
52-Week Range: $0.22 – $1.05  
Market Cap: Approximately $75–80?million  
Average Daily Volume: ~150,000 shares  
Real-time Volatility & Movers: +7–12% intraday moves not uncommon 
AVAI
jimmybob jimmybob 12 minutes ago
GM FOLKSSS
hedge_fun hedge_fun 13 minutes ago
This is the future and the robots are…….

coming as well, which is what is driving the share price.

Happy Taco Tuesday!
TSLA
stocktowatch stocktowatch 15 minutes ago
$GNLX Update! Preliminary data from Genelux’s Phase 1b trial in platinum-relapsed/refractory small cell lung cancer (SCLC) shows early promise for Olvi-Vec immunochemotherapy.
https://x.com/Genelux_Corp/status/1937231860674744489
GNLX
bigrun bigrun 16 minutes ago
Did you buy this at 0.009 and sold at 0.003….???? Lmfao
TWOH
Edgenation Edgenation 17 minutes ago
Was above $42 in pre-market !
IONQ OKLO SOUN
JayB2022 JayB2022 22 minutes ago
Seems that way. 
NTRR
budfoxfun budfoxfun 23 minutes ago
Raynor envisions SGTM playing a pivotal role in global sustainability efforts. The company aims to expand its impact by introducing its technologies and products to international markets, particularly in regions grappling with environmental challenges. By transforming waste into valuable resources,
SGTM
DMC8 DMC8 23 minutes ago
https://patentlyo.com/patent/2025/06/infringement-tinderbox-inducement.html
AMRN
esi23 esi23 24 minutes ago
Good point Nebraska this will shock some folks when it explodes up to 05 to .10 to .20.  
Skipping Pennie's like the old days 
BMXI
Jahvik Jahvik 24 minutes ago
There is an ignore button for ppl that do not add value 
AHRO
JoeForkeyBolo JoeForkeyBolo 25 minutes ago
Form 8-K filed for Annual Shareholders Meeting results.

https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=319258176&type=HTML&symbol=NVAX&cdn=00b9d41bc5e448355ceeaa32819ee362&companyName=Novavax+Inc.&formType=8-K&dateFiled=2025-06-24 Form 8-K
NVAX
budfoxfun budfoxfun 26 minutes ago
Water Conservation for Sustainable Growth $SGTM -Effective water management is crucial in both home gardens and large-scale landscapes. With increasing water scarcity, gardeners seek water-saving solutions to keep their plants hydrated while reducing overall water usage. Drip irrigation systems are
SGTM
tw0122 tw0122 26 minutes ago
11.3 million shares at .85...  (IBIO) filed a preliminary prospectus for the sale of up to around 11.3 million shares of its common stock by certain selling stockholders.The shares are issuable upon the exercise of warrants sold to the selling stockholders in a private placement completed on April 3
IBIO
Alex125 Alex125 26 minutes ago
Since EMA needs about 210 days to evaluate a drug when will the decision about blarcamesine will be taken? Has anybody any estimation when to expect it? 
AVXL
op1 op1 27 minutes ago
Agree however kidron ceo skills are poor at best
WDDD

Your Recent History

Delayed Upgrade Clock